Immunoglobulin G Antibody, a protective protein produced by the immune system in response to the presence of a foreign substance. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
This report contains market size and forecasts of Immunoglobulin G Antibody Therapeutics in Global, including the following market information:
Global Immunoglobulin G Antibody Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immunoglobulin G Antibody Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IgG1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunoglobulin G Antibody Therapeutics include Roche, Abbvie, J & J, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunoglobulin G Antibody Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunoglobulin G Antibody Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, by Type, 2021 (%)
IgG1
IgG4
Others
Global Immunoglobulin G Antibody Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, by Application, 2021 (%)
Autoimmune
Tumor
Others
Global Immunoglobulin G Antibody Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immunoglobulin G Antibody Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunoglobulin G Antibody Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immunoglobulin G Antibody Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca